Archives: Speakers

A business outcome executive working with C-suite leaders to align organizational strategies. Driving enterprise growth by aligning corporate strategy across multiple technology platforms including but not limited to artificial intelligence and machine learning, digital transformation, smart cities, smart stadiums, enterprise resource planning, customer experience, hyperscalers, and private cloud.”

Michael and his wife were both born and raised in beautiful St. Petersburg, Florida. They have two wonderful daughters that continually keep them busy and entertained. He graduated with his undergraduate degree from the University of Florida and received an MBA from the University of South Florida.

In 2010, he began his financial career by joining his father at Amuni, working on the firm’s fixed income trading desk. Following his father’s retirement in 2016, Michael assumed the role of President and CEO of Amuni.

At Amuni, Michael couldn’t ask for a more dedicated, friendly, and unique group of individuals. He truly enjoys coming to work every day. He is the fourth generation of his family to be involved in the financial services industry, and he takes the many roles that they play in their customers’ lives very seriously. Michael takes pride in treating their customers as part of their family.

Over the years, Michael has supported and has been a part of numerous charitable organizations including Johns Hopkins All Children’s Hospital, Pinellas County Education Foundation, Tampa Bay Watch, Children’s Dream Fund, CASA, and many other great organizations.

In his spare time, Michael enjoys spending time with his family on the water, in the mountains, and in the air. He has been a private pilot for over 25 years and learned to fly as a teenager at Albert Whitted Airport in downtown St. Pete.

Maxime Krief, currently Vice President of Strategic Solutions at Amuni Financial, Inc. in St. Petersburg, FL, has a diverse background in both international business and digital transformation. Maxime graduated with a Bachelor of Science, double majoring in International Business Finance and Management. His practical experience extends to his tenure at an American food exporter, where he worked on promoting American food products in the Middle East and Africa.

Maxime is a certified Quick Base App Builder and Quick Base Expert Builder. By leveraging technological tools, he was part of a team that successfully redesigned operations and compliance processes at Amuni Financial, a feat he will be sharing insights on during his talk on “Digital Transformation in Wealth Management.”

Outside of his professional achievements, Maxime is a member of the French American Chamber of Commerce (FRAMCO), an association committed to fostering relationships and sharing professional experiences between the French and Americans.

Born and raised in France, Maxime moved to the U.S. in 2007. Now, he enjoys life in sunny Florida with his wife and two children, dedicating his free time to family activities and adventures.

Jan Nielsen, has more than 16 years of experience in product design, validation, implementation, and support of eClinical and CRM software systems at international pharma, biotech, med-tech and CRO. He graduated from Copenhagen University College of Engineering in 1990 and started his career in Switzerland in a global industrial company , soon becoming head of electrical and software development. In 2007 Jan moved to BSI to help build up their life sciences business as provider of eClinical software systems, where he is today working as Community Manager Life Sciences.

Mary M. Deatherage led The Deatherage Group at Morgan Stanley Private Wealth Management, providing comprehensive wealth planning, asset allocation, investment management including social impact investing, tax, trust and estate strategies, philanthropy management and family wealth education along with lifestyle advisory services. Her clientele consists of high-net-worth individuals and families as well as large foundations and pension plans.

 Mary started her financial career as a CPA and audit manager at Coopers & Lybrand in New York City and Detroit, where she specialized in acquisition and divestiture reviews for clients such as CBS, Sanofi and Fortune Brands. She subsequently became a financial advisor and has been with Morgan Stanley since 1986.

 Mary has received numerous industry honors and distinctions. For seventeen consecutive years, Barron’s has named her one of their “Top 1,200 Advisors” in the US. In 2022, Barron’s named Mary #19 in its survey of “Top Women Financial Advisors in America”, and she was recognized as one of 2021’s “Top 100 Financial Advisors”. She is a Barron’s “Hall of Fame Advisor.” Also in 2022, Forbes Magazine named her #15 on their “Top Women Wealth Advisors” list and #4 on their “America’s Best-in- State Private Wealth Advisors: New Jersey” list. In 2022, Forbes ranked Mary #154 on their “America’s Top Wealth Advisors” list. Mary was named a “MAKER: Women Who Make America” as a representative of Morgan Stanley in 2014.

 Mary has appeared on CNBC, Fox Business and National Public Radio (NPR). She has written several focus pieces in Barron’s and contributed to the New York Times and Worth magazine. She received her undergraduate degree in education from Mount St. Mary College, and her accounting degree from the University of Arizona.

Estelle Jobson is a EUPATI Fellow and patient expert, living with endometriosis. She has an MSc in Publishing, from New York University, attended on a Fulbright scholarship, and decades of experience in editing and managing publications for health-related, academic, and educational institutions.

Since 2019, she has been a patient partner at the Geneva University Hospitals (HUG), notably exploring how investigators can embed patient-centricity in their studies. Estelle works as Account Director and Patient Lead at a Geneva-based health communications agency, Infinity Communications. Her key interests include: patient engagement in R&D and trial design, lay summaries, patient-centric resources, patient-reported outcomes, and risk–benefit communications.

Harald Wagner, has 30 years of experience in drug manufacturing, research & development in various sponsor- and CRO functions with his background in pharmaceutical technology. During the recent decades his focus has been on Clinical Operations of large scale and long-term Clinical Studies, as well as pioneer projects establishing new processes and clinical systems early, such as EDC, Risk-based Monitoring, eTMF, CTMS, wearables, ePROs or Decentralized Clinical Trials, leading the Clinical Operations department of the European CRO AMS Advanced Medical Services